{"id":627734,"date":"2024-04-10T10:40:31","date_gmt":"2024-04-10T14:40:31","guid":{"rendered":"https:\/\/www.singlecare.com\/blog\/?p=627734"},"modified":"2024-10-25T10:01:19","modified_gmt":"2024-10-25T14:01:19","slug":"mydayis-vs-vyvanse","status":"publish","type":"post","link":"https:\/\/www.singlecare.com\/blog\/mydayis-vs-vyvanse\/","title":{"rendered":"Mydayis vs Vyvanse: Differences, similarities, and which one is better for you"},"content":{"rendered":"

Mydayis<\/span><\/a> and <\/span>Vyvanse<\/span><\/a> are two brand-name medications used to treat attention deficit hyperactivity disorder (<\/span>ADHD<\/span><\/a>). ADHD medications are one part of a treatment plan that generally includes other measures like behavioral therapy and educational or work interventions. Vyvanse is also approved by the U.S. Food and Drug Administration (FDA) to treat moderate to severe <\/span>binge eating disorder<\/span><\/a> in adults. <\/span><\/p>\n

Mydayis and Vyvanse are classified in a group of medications called <\/span>central nervous system stimulants<\/span><\/a>. They work by increasing levels of neurotransmitters (chemical messengers) called dopamine and norepinephrine in the brain. This improves symptoms of ADHD, such as impulsivity or hyperactivity, helping the patient pay attention and focus. Because they have a high potential for abuse, misuse, and dependence, Mydayis and Vyvanse are classified by the <\/span>DEA<\/span><\/a> as Schedule II <\/span>controlled substances<\/span><\/a>. Although both medications are CNS stimulants used for the treatment of ADHD, they have some differences, which we will discuss below. <\/span><\/p>\n

What are the main differences between Mydayis and Vyvanse?<\/span><\/h2>\n

Both Mydayis and Vyvanse are central nervous system stimulants and are long-acting medications. Both are available in capsule form; Vyvanse also has a chewable tablet formulation. Mydayis is FDA approved for use in adults and pediatric patients 13 years and older, while Vyvanse can be used in adults and children 6 years and older for ADHD. <\/span><\/p>\n

Both medications are classified by the DEA as Schedule II controlled substances. However, lisdexamfetamine, the ingredient in Vyvanse, is known as a prodrug. This means it is inactive until it is converted in the body to its active ingredient, dextroamphetamine. This mechanism lowers the abuse potential of Vyvanse.<\/span><\/p>\n

The chart below outlines more information about available formulations and dosing.<\/span><\/p>\n\n\n\n\n\n\n\n\n\n\n\n\n\n
\n

Main differences between Mydayis and Vyvanse<\/span><\/h2>\n<\/th>\n<\/tr>\n<\/thead>\n

<\/td>\nMydayis <\/b><\/td>\nVyvanse<\/b><\/td>\n<\/tr>\n
Drug class<\/b><\/td>\nCentral nervous system (CNS) stimulant<\/span><\/td>\nCentral nervous system (CNS) stimulant<\/span><\/td>\n<\/tr>\n
DEA drug schedule<\/b><\/td>\nSchedule II controlled substance<\/span><\/td>\nSchedule II controlled substance<\/span><\/td>\n<\/tr>\n
Brand\/generic status<\/b><\/td>\nBrand and generic<\/span><\/td>\nBrand and generic<\/span><\/td>\n<\/tr>\n
What is the generic name?<\/b><\/td>\nD<\/span>extroamphetamine sulfate, amphetamine sulfate, dextroamphetamine saccharate, amphetamine aspartate monohydrate (some generics have been approved but may not be available in pharmacies yet)<\/span><\/td>\nLisdexamfetamine dimesylate (also referred to as lisdexamfetamine)<\/span><\/td>\n<\/tr>\n
What form(s) does the drug come in?<\/b><\/td>\nExtended-release capsules: 12.5 mg, 25 mg, 37.5 mg, 50 mg (these capsules contain 3 kinds of beads that release the medicine: an immediate-release and two different types of delayed-release beads)<\/span><\/td>\nCapsules: 10 mg, 20 mg, 30 mg, 40 mg, 50 mg, 60 mg, 70 mg<\/span><\/p>\n

Chewable tablets: 10 mg, 20 mg, 30 mg, 40 mg, 50 mg, 60 mg<\/span><\/td>\n<\/tr>\n

What is the standard dosage?<\/b><\/td>\nAdults: The starting dose is <\/span>12.5 or 25 mg by mouth daily in the morning. The healthcare provider may gradually increase the dose, if needed, to a maximum of 50 mg once daily <\/span><\/p>\n

Pediatric patients 13-17 years old: <\/span>The starting dose is <\/span>12.5 mg by mouth daily in the morning. The healthcare provider may gradually increase the dose, if needed, to a maximum of 25 mg once daily <\/span><\/p>\n

A dose of Mydayis can last up to 16 hours, so it is taken as one daily dose.<\/span><\/td>\n

Adults and children 6 years and older<\/span><\/a>: The starting dose is 30 mg by mouth once daily. <\/span>The healthcare provider may gradually increase the dose, if needed, to a maximum of 70 mg once daily <\/span><\/p>\n

A dose of Vyvanse can last up to 14 hours, so it is taken as one daily dose.<\/span><\/td>\n<\/tr>\n

How long is the typical treatment?<\/b><\/td>\nVaries<\/span><\/td>\nVaries <\/span><\/td>\n<\/tr>\n
Who typically uses the medication?<\/b><\/td>\nAdults and pediatric patients ages 13 and older <\/span><\/td>\nADHD: Adults and children 6 years and older<\/span><\/p>\n

Binge eating disorder: Adults only<\/span><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n

Conditions treated by Mydayis and Vyvanse<\/span><\/h2>\n

Mydayis and Vyvanse are both used as part of a treatment plan for <\/span>ADHD<\/span><\/a>. Mydayis can be used in individuals who are 13 years and older, while Vyvanse can be used in individuals who are 6 years and older. <\/span><\/p>\n

Additionally, Vyvanse is approved for moderate to severe binge eating disorder (note: it is <\/span>not<\/b> approved for weight loss) in adults. For this use, it is not approved in pediatric patients.<\/span><\/p>\n\n\n\n\n\n
Condition<\/b><\/td>\nMydayis<\/b><\/td>\nVyvanse<\/b><\/td>\n<\/tr>\n
ADHD<\/span><\/td>\nYes (ages 13 years and older)<\/span><\/td>\nYes (ages 6 years and older)<\/span><\/td>\n<\/tr>\n
Moderate to severe binge eating disorder<\/span><\/td>\nNo <\/span><\/td>\nYes (adults only)<\/span><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n

Is Mydayis or Vyvanse more effective?<\/span><\/h2>\n

There are two types of stimulant drugs—methylphenidate drugs such as <\/span>Concerta<\/span><\/a>, <\/span>Ritalin<\/span><\/a>,  or <\/span>Focalin<\/span><\/a>, and amphetamine drugs. Both Mydayis and Vyvanse (along with drugs such as <\/span>Adderall<\/span><\/a> and <\/span>Adderall XR<\/span><\/a>) are examples of amphetamine-type stimulants. There is little data comparing Mydayis and Vyvanse directly. <\/span><\/p>\n

For children or adolescents with ADHD, the <\/span>American Academy of Pediatrics (<\/span>AAP<\/span><\/a>) recommends:<\/span><\/p>\n